Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Healthtrust
Cerilliant
Argus Health
Chubb
US Army
Dow
Merck
McKinsey
Moodys

Generated: October 23, 2017

DrugPatentWatch Database Preview

CITALOPRAM HYDROBROMIDE Drug Profile

« Back to Dashboard

Which patents cover Citalopram Hydrobromide, and when can generic versions of Citalopram Hydrobromide launch?

Citalopram Hydrobromide is a drug marketed by Apotex Inc, Jubilant Generics, Aurobindo Pharma Ltd, Teva Pharms, Torrent Pharms, Silarx, Aurobindo, Pliva, Sun Pharm Inds Inc, Actavis Elizabeth, Invagen Pharms, Watson Labs, Sandoz, Epic Pharma Llc, Mylan Pharms Inc, Dr Reddys Labs Ltd, Mylan, Natco Pharma Ltd, Roxane, West-ward Pharms Int, Cipla Ltd, Epic Pharma, Torpharm, G And W Labs Inc, Hetero Labs Ltd Iii, Sun Pharm Inds, Glenmark Generics, Biovail Labs Intl, Taro, and Amneal Pharms Ny. and is included in thirty-three NDAs.

The generic ingredient in CITALOPRAM HYDROBROMIDE is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.

Summary for Tradename: CITALOPRAM HYDROBROMIDE

US Patents:0
Applicants:30
NDAs:33
Suppliers / Packagers: see list67
Bulk Api Vendors: see list74
Clinical Trials: see list200
Patent Applications: see list1,185
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CITALOPRAM HYDROBROMIDE at DailyMed

Pharmacology for Tradename: CITALOPRAM HYDROBROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077052-002Jul 3, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077038-002Oct 28, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077035-002Oct 28, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms Ny
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077289-001Nov 30, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Natco Pharma Ltd
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077141-002Apr 10, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Cipla Ltd
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077044-003Nov 5, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077039-003Feb 3, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Natco Pharma Ltd
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077141-001Apr 10, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077042-002Nov 5, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Epic Pharma
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077045-003Apr 29, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
QuintilesIMS
Colorcon
Farmers Insurance
Chinese Patent Office
Accenture
UBS
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot